Clinical Trials Logo

Iron Deficiency clinical trials

View clinical trials related to Iron Deficiency.

Filter by:

NCT ID: NCT03703739 Active, not recruiting - Iron-deficiency Clinical Trials

Iron Absorption From Iron Fortified Extruded Rice Co-fortified With Various Solubilizing Agents

Start date: October 2, 2018
Phase: N/A
Study type: Interventional

Food fortification is regarded as a safe and cost-effective approach to counteract and prevent iron deficiency. Rice is a staple food for millions of people living in regions where iron-deficiency anaemia is a significant public health problem. Therefore, rice may be a promising fortification vehicle. Ferric pyrophosphate (FePP) is an acceptable iron compound for rice fortification, due to its white colour and low reactivity with the rice matrix. However, iron from FePP generally has a low bioavailability. To increase the low iron bioavailability of FePP in fortified rice, ligands acting as solubilizing agents have been suggested, such as citric acid/trisodium citrate (CA/TSC), ethylenediaminetetraacetic acid (EDTA) and sodium pyrophosphate (NaPP). It is however unclear to which extent CA/TSC would enhance iron bioavailability in presence of phytic acid, a common inhibitor of iron absorption found in whole grains and legumes. Zinc oxide reduces iron bioavailability from FePP with and without CA/TSC, in contrast to Zinc sulphate. It is however unclear if this decrease would be also expected in presence of EDTA as solubilizing agent. Further, NaPP has been suggested as a solubilizing agent, enhancing the bioavailability from FePP in bouillon cubes. This study aim to test its effect in rice. Meals containing a high (bean sauce) and low (mixed vegetable) phytic acid level sauce will be used to simulated varying dietary backgrounds, allowing to answer the question which solubilizing agent is viable in enhancing iron bioavailability.

NCT ID: NCT03703726 Active, not recruiting - Iron-deficiency Clinical Trials

Iron Absorption From Fortified Extruded Rice Using Different Extruding Temperatures.

Start date: September 25, 2018
Phase: N/A
Study type: Interventional

Food fortification is regarded as a safe and cost-effective approach to counteract and prevent iron deficiency. Rice is a staple food for millions of people living in regions where iron-deficiency anaemia is a significant public health problem. Therefore, rice may be a promising fortification vehicle. Hot and cold extrusion, have been identified as the major methods for rice fortification. Extruded rice has the advantage of incorporating vitamins and minerals into the food matrix. Cold, warm and hot extrusion differ in the processing temperature and the physical structure of fortified rice kernel matrix. A recent human study in young women showed fractional iron absorption was higher in cold extruded rice compared to hot extruded Rice and this was associated with changes in the starch microstructure. These changes cannot be detected in warm extruded rice, thus, our aim is to test the iron bioavailability in difference extrusion methods; hot and warm and cold with and without the solubilizing agent CA/TSC. This will provide information on optimized rice formulations for optimal iron delivery.

NCT ID: NCT03660462 Completed - Iron-deficiency Clinical Trials

Iron Bioavailability of High Surface Area Ferric Phosphate

HiFe
Start date: November 21, 2018
Phase: N/A
Study type: Interventional

The primary objective of this study is to compare iron absorption of high surface area ferric phosphate with that of ferrous sulfate and bulk ferric phosphate in a rice-based meal in non-pregnant women.

NCT ID: NCT03646487 Completed - Clinical trials for Stress, Psychological

A Randomized Placebo Controlled Pilot Study of Probiotic Supplementation in At-risk Pregnant Women

Start date: November 19, 2018
Phase: N/A
Study type: Interventional

The goal of this randomized supplementation feasibility trial is to learn about the feasibility and preliminary efficacy of the probiotic, lactobacillus plantarum 299v (Lp299v), in pregnant individuals at-risk for iron deficiency anemia. The main questions it aims to answer are: - Is daily oral Lp299v a feasible and tolerable intervention for pregnant individuals to uptake? - Does daily oral Lp299v in pregnancy impact maternal and neonatal cord hematological and iron status parameters? Participants will be randomly assigned to one of two treatment groups: daily intake or probiotic Lp299v + prenatal vitamin with iron or placebo + prenatal vitamin with iron from 15-20 weeks of gestation through delivery. Researchers will compare the two treatment groups to see if there is a difference in the feasibility of the intervention and the preliminary efficacy on maternal and neonatal cord hematological and iron status parameters.

NCT ID: NCT03642223 Completed - Iron-deficiency Clinical Trials

Central and Peripheral Adiposity and Iron Absorption

Start date: September 10, 2017
Phase: N/A
Study type: Interventional

Adiposity is a state of sub-clinical inflammation, thus hepcidin is increased in adiposity, often leading to iron deficiency in this population group. Central adiposity is generally considered having a greater negative effect on health compared to peripheral adiposity. Whether this can be also seen in hepcidin and thereby in iron absorption is uncertain.

NCT ID: NCT03632525 Completed - Cystic Fibrosis Clinical Trials

Intravenous Iron in Adults With Cystic Fibrosis

Start date: February 22, 2019
Phase: Phase 4
Study type: Interventional

This pilot interventional cohort study will examine the effects of intravenous iron in adults with cystic fibrosis and iron deficiency.

NCT ID: NCT03617575 Completed - Iron-deficiency Clinical Trials

The Effect of Lactoferrin and Dosing Regimen on Iron Absorption From a Maize-based Porridge in Kenyan Infants

Start date: December 11, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to measure iron absorption from maize-based porridge fortified with either apo-lactoferrin, holo-lactoferrin or ferrous sulfate and to test whether there is an effect of these. Additionally, iron absorption from maize-based porridge containing 12 mg ferrous sulfate will be measured when consumed every other day versus every third day.

NCT ID: NCT03606993 Completed - Clinical trials for Iron Deficiency Anemia

Iron Fish for Dominican Republic (DR) Infants

Start date: August 13, 2018
Phase: N/A
Study type: Interventional

This study evaluates the feasibility of cooking with an iron ingot, Lucky Iron Fish™ (LIF), and evaluate the natural history of hemoglobins and iron status among infants of families using this iron ingot in a population with a high prevalence of iron-deficiency anemia. Participants are mother-infant dyads, and are randomized to one of two arms: Lucky Iron Fish™or enhanced standard of care.

NCT ID: NCT03596996 Completed - Hiv Clinical Trials

Optimizing Iron Status While Minimizing Morbidity in HIV-infected Ugandan Children

Start date: April 19, 2018
Phase: N/A
Study type: Interventional

Randomized, placebo-controlled trial of the effect of 84 days of daily iron supplementation on iron status, gut microbiome profile, infectious disease frequency, and HIV disease severity in moderately anemic [hemoglobin 9 - <11 g/dL (6-59 mo); hemoglobin 9 - < 11.5 g/dL (5 -12 years)], HIV-infected Ugandan children between the ages of 6 mos and 12 years.

NCT ID: NCT03572010 Completed - Iron-deficiency Clinical Trials

Stable Iron Isotope Method in HIV+ and HIV- Children

Start date: September 27, 2018
Phase: N/A
Study type: Interventional

The objective of this study is to compare HIV infected children to uninfected children regarding 1) quantifying iron absorption from iron fortified maize porridge, lipid-based food supplements and oral iron supplements, and 2) quantifying the daily iron requirement.